BridgeMD
New treatment option for Aortic Aneurysm
Official title Utilizing 3D Printed Personalized Aortic Lesion Models in Preoperative Assessment
ClinicalTrials.gov ID: NCT06147024
What this study is testing
- What it's testing
- Using 3D printing technology to create personalized models of diseased heart and aortic blood vessels, surgeons can perform preoperative planning and evaluate relevant indicators.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Diagnosed with thoracic or abdominal aortic aneurysm
- Signed surgical consent
- Non-emergent surgery
- Had 2D CT imaging within the last 6 months
You likely can't join if
- Refusal to use lesion images for model creation
- Refusal to participate in the study
The study team makes the final eligibility decision.
Where it's taking place
- New Taipei City, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New Taipei City, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.